These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38265606)

  • 41. Patent foramen ovale closure in children without cardiopathy: Child-PFO study.
    Miton N; Godart F; Milani G; Jalal Z; Karsenty C; Baruteau AE; Gronier C; Aldebert P; Douchin S; Lucron H; Chalard A; Houeijeh A; Petit J; Hascoet S; Thambo JB; Dauphin C
    Arch Cardiovasc Dis; 2020; 113(8-9):513-524. PubMed ID: 32680737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Percutaneous Patent Foramen Ovale Closure: Stroke and Beyond.
    Randhawa S; Mehta JL; Dhar G
    Curr Cardiol Rev; 2024; 20(3):77-86. PubMed ID: 38485682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Performance of the New Gore Septal Occluder in Patent Foramen Ovale Closure: A Single-Center Experience.
    Sganzerla P; Rondi M; Pavone A; Aiolfi E; Facchinetti A; Funaro A; Negrini P
    J Invasive Cardiol; 2015 Sep; 27(9):430-4. PubMed ID: 26332878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcranial doppler quantification of residual shunt after percutaneous patent foramen ovale closure: efficacy of the GORE(®) HELEX septal occluder.
    Sorensen SG; Smout R; Spruance SL
    J Interv Cardiol; 2011 Aug; 24(4):366-72. PubMed ID: 21492220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU study.
    Sievert H; Wunderlich N; Reiffenstein I; Ruygrok P; Grube E; Buellesfeld L; Meier B; Schofer J; Muller D; Jones RK; Gillam L
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1135-43. PubMed ID: 22815250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
    J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up.
    Van den Branden BJ; Post MC; Plokker HW; ten Berg JM; Suttorp MJ
    JACC Cardiovasc Interv; 2010 Sep; 3(9):968-73. PubMed ID: 20850098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
    Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
    Arch Cardiovasc Dis; 2019; 112(8-9):532-542. PubMed ID: 31378692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
    Van de Bruaene A; Stroobants D; Benit E
    Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New PFO device for closure of patent foramen ovale in patients who had a history of cryptogenic stroke; a report of 14 cases.
    Srimahachota S; Sansanayudh N; Lertsuwunseri V; Cholteesupachai J; Lertsapcharoen P
    J Med Assoc Thai; 2015 Jan; 98 Suppl 1():S107-10. PubMed ID: 25764621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
    Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Importance of Persistent Right-to-Left Shunt After Patent Foramen Ovale Closure in Cryptogenic Stroke Patients.
    He L; Cheng G; Du Y; Zhang Y
    Tex Heart Inst J; 2020 Aug; 47(4):244-249. PubMed ID: 33472221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: An Update.
    Abdelghani M; El-Shedoudy SAO; Nassif M; Bouma BJ; de Winter RJ
    Cardiology; 2019; 143(1):62-72. PubMed ID: 31307049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk mitigation in divers with persistent (patent) foramen ovale.
    Wilmshurst P
    Diving Hyperb Med; 2019 Jun; 49(2):77-78. PubMed ID: 31177512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
    Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION).
    Puricel S; Arroyo D; Goy JJ; Praz F; Palhais N; Wahl A; Stauffer JC; Togni M; Berger A; Meier B; Cook S
    EuroIntervention; 2015 Jun; 11(2):230-7. PubMed ID: 24830681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure.
    Vitarelli A; Mangieri E; Capotosto L; Tanzilli G; D'Angeli I; Toni D; Azzano A; Ricci S; Placanica A; Rinaldi E; Mukred K; Placanica G; Ashurov R
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1377-85. PubMed ID: 25139906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke.
    Kent DM; Saver JL; Kasner SE; Nelson J; Carroll JD; Chatellier G; Derumeaux G; Furlan AJ; Herrmann HC; Jüni P; Kim JS; Koethe B; Lee PH; Lefebvre B; Mattle HP; Meier B; Reisman M; Smalling RW; Soendergaard L; Song JK; Mas JL; Thaler DE
    JAMA; 2021 Dec; 326(22):2277-2286. PubMed ID: 34905030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.